Neuronetics, Inc. (STIM) analyst actions
Rating and price-target actions on STIM in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the STIM overview →
1 measured STIM analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| NeuroStar® Releases Software Upgrades to Elevate Patient Care | Press release | -0.65% | +4.00% |
Keep exploring
More STIM: earnings → · SEC filings → · STIM overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| UROVANT SCIENCES LTD COMMON (UROV) | 397 | 0.00% | 49% |
| Bruker Corporation (BRKR) | 395 | -0.10% | 46% |
| Axogen, Inc. (AXGN) | 393 | -0.12% | 48% |
| Fulgent Genetics, Inc. (FLGT) | 393 | +0.04% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.